Replacing 10 percent of ultra-processed foods with healthier alternatives lowered diabetes risk by up to 18 percent, a new study says.

The study builds on a growing body of research suggesting 3D mammography could offer benefits over 2D imaging.

At the end of her new memoir, Hillary Clinton offers up what sounds like a far-off wish: “I hope I’m alive to see the United ...

Palantir signed a multi-year contract with Nebraska Medicine to enhance healthcare through AI technologies using its AIP platform. The partnership will focus on improving patient flow, nurse ...

Disc Medicine (IRON – Research Report), the Healthcare ... Analyst Douglas Tsao from H.C. Wainwright reiterated a Buy rating on the stock and has a $70.00 price target. Douglas Tsao has given ...

Palantir Technologies Inc. (NYSE: PLTR) ("Palantir"), and Nebraska Medicine, a $2.5B academic health system based in Omaha, and a national leader in healthcare innovation, today announced a new ...

Aug. 30, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ ... does not mean that the stock will go down. For example, biotech and... Presented positive data for all three programs at the ...

12, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel ...

Fidelity Covington Trust - Fidelity Disruptive Medicine ETF is an open-end equity ... It employs fundamental and quantitative analysis with bottom-up stock picking approach to create its portfolio.

Most trillion-dollar companies today are in the technology sector, but one particular healthcare stock is knocking on the ...

H.C. Wainwright has recently initiated Prime Medicine Inc (PRME) stock to Buy rating, as announced on May 20, 2024, according to Finviz. Earlier, on May 16, 2024, Citigroup had raised the stock from a ...